Backs FY25 revenue view $415M-$420M, consensus $418.33M. Backs FY25 adjusted EBITDA margin view approximately 32%. The company said last night, “As part of this announcement, the Company is reaffirming its 2025 full year financial outlook as previously disclosed on November 6, 2025.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERT:
- Certara price target lowered to $12 from $15 at Stephens
- Certara’s Strategic Transition: Balancing Growth Prospects with Short-term Uncertainties
- Certara Appoints Jon Resnick as New CEO
- Certara appoints Jon Resnick as CEO, William Feehery to step down December 31
- FDA guides on streamlined nonclinical monoclonal antibody safety studies